Bing‐Ching Ho
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
-
- Lung Cancer Treatments and Mutations
Papers in
-
- Cancer Genomics and Diagnostics 4
- MicroRNA in disease regulation 3
- Cancer-related molecular mechanisms research 2
-
- RNA regulation and disease 5
- RNA Research and Splicing 4
- Co-authors
- Sung‐Liang Yu (21 shared papers)Pan‐Chyr Yang (11 shared papers)Kang‐Yi Su (9 shared papers)Gee‐Chen Chang (4 shared papers)Min‐Liang Kuo (2 shared papers)Ker-Chau Li (2 shared papers)James Chih‐Hsin Yang (1 shared paper)Wing‐Kai Chan (1 shared paper)
- Journals
- Oncotarget (3 papers)PLoS ONE (3 papers)Scientific Reports (2 papers)Journal of Cellular Biochemistry (2 papers)Cellular Microbiology (2 papers)
- Partner nations
- TaiwanUnited StatesAustralia
In The Last Decade
Bing‐Ching Ho
28 papers receiving 1.2k citations
Bing‐Ching Ho's Hit Papers
Peers
Comparison fields: 5 of 101
- Cancer Research 370
- Pulmonary and Respiratory Medicine 376
- Oncology 251
- Molecular Biology 559
- Immunology 149
Countries citing papers authored by Bing‐Ching Ho
This map shows the geographic impact of Bing‐Ching Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing‐Ching Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing‐Ching Ho more than expected).
Fields of papers citing papers by Bing‐Ching Ho
This network shows the impact of papers produced by Bing‐Ching Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing‐Ching Ho. The network helps show where Bing‐Ching Ho may publish in the future.
Co-authors
The 25 scholars most cited alongside Bing‐Ching Ho, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pretreatment Epidermal Growth Factor Receptor ( EGFR ) T790M Mutation Predicts Shorter EGFR Tyrosine Kinase Inhibitor Response Duration in Patients With Non–Small-Cell Lung Cancer Hit paper breakdown → | 2012 | 444 |
| 2 | 2011 | 130 | |
| 3 | 2014 | 124 | |
| 4 | 2015 | 81 | |
| 5 | 2013 | 49 | |
| 6 | 2009 | 48 | |
| 7 | 2016 | 41 | |
| 8 | 2009 | 36 | |
| 9 | 2014 | 30 | |
| 10 | 2017 | 26 | |
| 11 | 2016 | 26 | |
| 12 | 2016 | 25 | |
| 13 | 2016 | 22 | |
| 14 | 2016 | 19 | |
| 15 | 2019 | 18 | |
| 16 | 2015 | 17 | |
| 17 | 2019 | 17 | |
| 18 | 2019 | 15 | |
| 19 | 2016 | 14 | |
| 20 | 2016 | 13 |
About Bing‐Ching Ho
Bing‐Ching Ho is a scholar working on Cancer Research, Molecular Biology, Cardiology and Cardiovascular Medicine, Oncology and Pulmonary and Respiratory Medicine, having authored 28 papers that have together received 1.2k indexed citations. Recurring topics across this work include Viral Infections and Immunology Research (5 papers), RNA regulation and disease (5 papers), Lung Cancer Treatments and Mutations (5 papers), Cancer Genomics and Diagnostics (4 papers), RNA Research and Splicing (4 papers), MicroRNA in disease regulation (3 papers), Lung Cancer Research Studies (2 papers) and Cancer-related molecular mechanisms research (2 papers). The work is most often cited by research in Cancer Research (370 citations), Pulmonary and Respiratory Medicine (376 citations), Oncology (251 citations), Molecular Biology (559 citations) and Immunology (149 citations). Bing‐Ching Ho has collaborated with scholars based in Taiwan, United States and Australia. Frequent co-authors include Sung‐Liang Yu, Pan‐Chyr Yang, Kang‐Yi Su, Gee‐Chen Chang, Min‐Liang Kuo, Ker-Chau Li, James Chih‐Hsin Yang, Wing‐Kai Chan, Jin‐Yuan Shih and Hsuan‐Yu Chen. Their work appears in journals such as Oncotarget, PLoS ONE, Scientific Reports, Journal of Cellular Biochemistry and Cellular Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.